Leaflet LATANOPROST/TIMOLOL TEVA 0.05mg / 5mg / ml ophthalmic drops solution


Indicated for: glaucoma; ocular hypertension

Substance: latanoprost + timolol (glaucoma agent + beta blocker)

ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)

The combination of latanoprost and timolol is used for the treatment of open-angle glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Latanoprost increases the outflow of aqueous humor, while timolol reduces its production.

The medication is administered as eye drops, usually once daily in the evening. It is important to follow the doctor's instructions to ensure treatment efficacy.

Side effects may include eye irritation, redness, changes in iris color, or dry eyes. In rare cases, allergic reactions, bradycardia, or macular edema may occur.

This combination is not recommended for patients with bronchial asthma, severe heart failure, or hypersensitivity to any of the components.

General data about LATANOPROST/TIMOLOL TEVA 0.05mg / 5mg / ml

  • Substance: latanoprost + timolol
  • Date of last drug list: 01-07-2013
  • Commercial code: W58549001
  • Concentration: 0.05mg / 5mg / ml
  • Pharmaceutical form: ophthalmic drops solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for latanoprost + timolol

Concentrations available for latanoprost + timolol

  • 0.05mg/5mg/ml
  • 50mcg/5mg/ml